Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Mar 24, 2020 · 10-K · 84 days after period end · 0001564590-20-012323
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Net Income | -$54.70M | -$38.79M |
| EPS Diluted | -$0.89 | -$4.92 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 24, 2020 · 84 d after period end
